Company Registration No. 12823998 (England and Wales)
Luna Therapeutics Limited
Unaudited accounts
for the year ended 31 August 2024
Luna Therapeutics Limited
Unaudited accounts
Contents
Luna Therapeutics Limited
Company Information
for the year ended 31 August 2024
Directors
Prof. Richard Day
Dr. Stephen France
Company Number
12823998 (England and Wales)
Registered Office
LBIC 1t Floor Amoroso Building
RVC Camden Campus
2, Royal CollegeStreet, London
NW1 oNH
United Kingdom
Accountants
Consept Accounting Solutions Ltd
73
Orchard Avenue
Watford
WD25 7JG
Luna Therapeutics Limited
Statement of financial position
as at 31 August 2024
Tangible assets
74,151
84,659
Cash at bank and in hand
222,319
264,123
Creditors: amounts falling due within one year
933
(5,133)
Net current assets
223,252
273,549
Total assets less current liabilities
297,403
358,208
Creditors: amounts falling due after more than one year
(602)
(599)
Net assets
296,801
357,609
Called up share capital
1
1
Profit and loss account
296,800
357,608
Shareholders' funds
296,801
357,609
For the year ending 31 August 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A - Small Entities. The profit and loss account has not been delivered to the Registrar of Companies.
The financial statements were approved by the Board of Directors and authorised for issue on 9 May 2025 and were signed on its behalf by
Prof. Richard Day
Director
Company Registration No. 12823998
Luna Therapeutics Limited
Notes to the Accounts
for the year ended 31 August 2024
Luna Therapeutics Limited is a private company, limited by shares, registered in England and Wales, registration number 12823998. The registered office is LBIC 1t Floor Amoroso Building, RVC Camden Campus, 2, Royal CollegeStreet, London, NW1 oNH, United Kingdom.
2
Compliance with accounting standards
The accounts have been prepared in accordance with the provisions of FRS 102 Section 1A Small Entities. There were no material departures from that standard.
The principal accounting policies adopted in the preparation of the financial statements are set out below and have remained unchanged from the previous year, and also have been consistently applied within the same accounts.
The accounts have been prepared under the historical cost convention as modified by the revaluation of certain fixed assets.
Tangible fixed assets and depreciation
Tangible assets are included at cost less depreciation and impairment. Depreciation has been provided at the following rates in order to write off the assets over their estimated useful lives:
Plant & machinery
Straight line method based on its useful life.
Fixtures & fittings
Straight line method based on its useful life.
Computer equipment
Straight line method based on its useful life.
4
Tangible fixed assets
Plant & machinery
Computer equipment
Total
Cost or valuation
At cost
At cost
At 1 September 2023
113,507
452
113,959
At 31 August 2024
113,507
452
113,959
At 1 September 2023
28,998
302
29,300
Charge for the year
10,357
151
10,508
At 31 August 2024
39,355
453
39,808
At 31 August 2024
74,152
(1)
74,151
At 31 August 2023
84,509
150
84,659
Amounts falling due within one year
Luna Therapeutics Limited
Notes to the Accounts
for the year ended 31 August 2024
6
Creditors: amounts falling due within one year
2024
2023
Taxes and social security
(15)
6,336
7
Creditors: amounts falling due after more than one year
2024
2023
Loans from directors
599
599
8
Average number of employees
During the year the average number of employees was 1 (2023: 1).